Nom du produit:3-cyclopropyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-4-(trifluoromethyl)aniline

IUPAC Name:3-cyclopropyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-4-(trifluoromethyl)aniline

CAS:2820116-37-6
Formule moléculaire:C16H21BF3NO2
Pureté:95%+
Numéro de catalogue:CM1051197
Poids moléculaire:327.15

Unité d'emballage Stock disponible Prix($) Quantité
CM1051197-100mg in stock ƓƓǵ
CM1051197-250mg in stock ȃȃȃƥ

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:2820116-37-6
Formule moléculaire:C16H21BF3NO2
Point de fusion:-
Code SMILES:CC1(C)OB(OC1(C)C)C1=CC(N)=CC(C2CC2)=C1C(F)(F)F
Densité:
Numéro de catalogue:CM1051197
Poids moléculaire:327.15
Point d'ébullition:
N° Mdl:
Stockage:

Category Infos

Cyclopropanes
Cyclopropane is the smallest cyclic compound with unique structural features and physicochemical properties, which is widely used in the design of small molecule drugs. In drug design, it is often used to increase activity, fix conformation and improve PK and water solubility. The introduction of cyclopropyl groups into drugs can change various properties of molecules, such as improving metabolic stability; increasing biological activity; enhancing drug efficacy; limiting polypeptide conformation and slowing down its hydrolysis; reducing plasma clearance; improving drug dissociation and many more. Cyclopropane rings are widely found in marketed drugs, including cardiovascular drugs, central nervous system (CNS) drugs, anticancer drugs, autoimmune and anti-inflammatory drugs.